Teva partners with Sanofi for Duvakitug development.

5 reports, 3 independent Updated Aug 5

Gone quiet

Reports: 5
Developments: 2
Repetition: 60%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Teva partners with Sanofi for Duvakitug development.

Who's involved

What this event is mainly about

Sanofi Teva Pharmaceutical Industries Ltd.

How it developed

Newest first. Tap a step to see who reported it.

Jul 7Advancing experimental vitiligo treatment (TEV-408) into Phase 2b.1 source
- ynetnews.com
Jun 26Teva and Sanofi announce a partnership to develop Duvakitug.

Keep exploring

Part of

Teva plans to launch Austedo in European markets and partnered with Sanofi for duvakitug. All 1 developments

The entities involved

Sanofi
company in Milan, Italy

Nothing else this week.
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
- Brian transitioned from a senior leadership role at Teva Pharmaceuticals to join Lupin Limited, where Vinita Gupta is CEO.Fri 11:19
- Deckers Brands reported strong earnings driven by Ugg and Hoka, while Stefano Caroti was named CEO of the company.Fri 02:46

Related events

Chris Fox, President of Teva USA, discussed drug pricing priorities for American patients.Aug 31

Coverage

Newest first; wire copies grouped

Aug 5biopharmadive.com
Jul 26fool.comTeva's Turnaround Is Working. Here's the 1 Thing That Could Send It Soaring Another 50%. | The Motley Fool
Jul 7ynetnews.com
Jun 26Unknown outlet

1 more outlet ran the same wire story

Jul 29yahoo.com